These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1250 related articles for article (PubMed ID: 17622529)

  • 21. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
    Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J;
    Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
    Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
    Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura.
    Delgado J; Bustos JG; Jimenez-Yuste V; Hernandez-Navarro F
    Haematologica; 2002 Feb; 87(2):215-6. PubMed ID: 11836172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.
    Parodi E; Nobili B; Perrotta S; Rosaria Matarese SM; Russo G; Licciardello M; Zecca M; Locatelli F; Cesaro S; Bisogno G; Giordano P; De Mattia D; Ramenghia U
    Int J Hematol; 2006 Jul; 84(1):48-53. PubMed ID: 16867902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
    Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Isola M; Buttignol S; Fanin R
    Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
    Aggarwal A; Catlett JP
    South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission.
    Louwes H; Vellenga E; Houwerzijl EJ; de Wolf JT
    Ann Hematol; 2001 Dec; 80(12):728-32. PubMed ID: 11797113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refractory autoimmune thrombocytopenic purpura: responses to treatment with a recombinant antibody to lymphocyte membrane antigen CD20 (rituximab).
    Narang M; Penner JA; Williams D
    Am J Hematol; 2003 Dec; 74(4):263-7. PubMed ID: 14635207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of treatment in immune thrombocytopenia.
    Jacobs P; Wood L; Dent DM
    Q J Med; 1986 Feb; 58(226):153-65. PubMed ID: 3714968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.
    Johansson E; Engervall P; Landgren O; Grimfors G; Widell S; Rezai S; Björkholm M
    Eur J Haematol; 2006 Jul; 77(1):61-6. PubMed ID: 16573739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response.
    Parodi E; Rivetti E; Amendola G; Bisogno G; Calabrese R; Farruggia P; Giordano P; Matarese SM; Nardi M; Nobili B; Notarangelo LD; Russo G; Vimercati C; Zecca M; De Mattia D; Ramenghi U
    Br J Haematol; 2009 Feb; 144(4):552-8. PubMed ID: 19036077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura.
    Winde G; Schmid KW; Lügering N; Fischer R; Brandt B; Berns T; Bünte H
    J Am Coll Surg; 1996 Dec; 183(6):565-74. PubMed ID: 8957458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
    Cooper N; Evangelista ML; Amadori S; Stasi R
    Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
    Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E
    Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of amifostine in treating patients with idiopathic thrombocytopenia purpura.
    Fan H; Zhu HL; Li SX; Lu XC; Zhai B; Guo B; Yao SQ; Liu Y
    Cell Biochem Biophys; 2011 Jan; 59(1):7-12. PubMed ID: 21104159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic idiopathic thrombocytopenic purpura (ITP) is a surgical disease.
    Szold A; Kais H; Keidar A; Nadav L; Eldor A; Klausner JM
    Surg Endosc; 2002 Jan; 16(1):155-8. PubMed ID: 11961628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.
    Aleem A
    Platelets; 2011; 22(1):1-7. PubMed ID: 20964585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.